Attomolar-Level Ultrasensitive and Multiplex microRNA Detection Enabled by a Nanomaterial Locally Assembled Microfluidic Biochip for Cancer Diagnosis

Yujin Chu,Yakun Gao,Wei Tang,Le Qiang,Yingkuan Han,Jianwei Gao,Yu Zhang,Hong Liu,Lin Han

DOI: https://doi.org/10.1021/acs.analchem.0c04896

IF: 7.4

2021-03-15

Analytical Chemistry

Abstract:Non-invasive early diagnosis is of great significance in disease pathologic development and subsequent medical treatments, and microRNA (miRNA) detection has attracted critical attention in early cancer screening and diagnosis. High-throughput, sensitive, economic, and fast miRNA sensing platforms are necessary to realize the low-concentration miRNA detection in clinical diagnosis and biological studies. Here, we developed an attomolar-level ultrasensitive, rapid, and multiple-miRNA simultaneous detection platform enabled by nanomaterial locally assembled microfluidic biochips. This platform presents a large linear detection regime of 1 aM–10 nM, an ultralow detection limit of 0.146 aM with no amplification, a short detection time of 35 min with multiplex miRNA sensing capability, and a small sample volume consumption of 2 μL. The detection results of five miRNAs in real samples from breast cancer patients and healthy humans indicate its excellent capacity for practical applications in early cancer diagnosis. The proposed ultrasensitive, rapid, and multiple-miRNA detection microfluidic biochip platform is a universal miRNA detection approach and an important and valuable tool in early cancer screening and diagnosis as well as biological studies.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c04896?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c04896</a>.The supplementary data associated with this article can be found.Schematic fabrication process of a double-layer microfluidic biosensing chip; DNA probes and miRNA sequences used in this study; work principle flow of the nanomaterial locally assembled microfluidic biochip; TEM, XRD, Raman spectrum, and absorption spectrum of GO and Raman and absorption spectra of PLL; surface morphology of the glass slide and GO-assembled glass slide; GO Raman scanning results of different positions on the glass substrate; FAM fluorescence group on the DNA probe and Raman scanning results of different positions on the GO assembled on the glass substrate surface; design diagram of miRNA detection process verification; detection process parameters optimization; detection result of different disease miRNAs using the five DNA probes and single- and double-base mismatch miRNA; sensitivity detection result of different miRNAs; detection limit of the target miRNA; properties of different representative miRNA detection platforms; miRNA concentration of each sample in TE buffer corresponding to Figure S11; spiked miRNA concentrations in serum samples corresponding to Figure 5; detection of miRNA spiked in TE buffer; experimental results of spiked miRNAs in serum samples as listed in Table S5; recovery percent of the actual detection miRNA concentration in TE buffer and serum; actual miRNA detected concentrations and relative deviations of each sample in TE buffer corresponding to Figure S11d–h; relative deviation between the actual detection concentration and theoretical concentration spiked in serum corresponding to Figure 6b; detected fluorescence intensity of miRNA in healthy and patient serum; detected concentrations of the miRNA biomarkers in serum samples from healthy persons; and detected concentrations of the miRNA biomarkers in serum samples from breast cancer patients (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c04896/suppl_file/ac0c04896_si_001.pdf">PDF</a>)Mechanism of the microfluidic chip (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c04896/suppl_file/ac0c04896_si_002.mp4">MP4</a>)miRNA sensing principle of the microfluidic chip (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c04896/suppl_file/ac0c04896_si_003.mp4">MP4</a>)This article has not yet been cited by other publications.

chemistry, analytical

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to achieve high - throughput, sensitive, economical and rapid detection of low - concentration microRNA (miRNA) in disease diagnosis and prognosis. Specifically, the researchers developed a microfluidic biochip platform based on local assembly of nanomaterials, aiming to achieve ultrasensitive, rapid and simultaneous detection of multiple miRNAs at the attomolar (10^-18 M) level. This platform has the following characteristics:

- **Wide linear detection range**: from 1 attomolar (aM) to 10 nanomolar (nM).
- **Extremely low detection limit**: reaching 0.146 aM without amplification.
- **Short detection time**: completing multi - miRNA detection within 35 minutes.
- **Small sample volume consumption**: only requiring 2 μL of sample.

This platform achieves the above - mentioned performance by using the reaction channels assembled with graphene oxide (GO) to fix DNA probes and the detection chambers assembled with poly - L - lysine (PLL) to collect DNA - miRNA complexes. These characteristics make this platform have important application value in early cancer screening and diagnosis, especially in the early detection of breast cancer. Through actual sample tests, this platform can effectively distinguish the miRNA expression levels between healthy individuals and breast cancer patients, showing its potential in clinical applications.